ZHX1 Antibody

Code CSB-PA026481GA01HU
Size $600
Order now
Have Questions? Leave a Message or Start an on-line Chat

Product Details

Uniprot No.
Target Names
ZHX1
Alternative Names
ZHX 1 antibody; ZHX1 antibody; ZHX1_HUMAN antibody; Zinc finger and homeodomain protein 1 antibody; Zinc fingers and homeobox 1 antibody; Zinc fingers and homeoboxes 1 antibody; Zinc fingers and homeoboxes protein 1 antibody
Raised in
Rabbit
Species Reactivity
Human,Mouse,Rat
Immunogen
Human ZHX1
Immunogen Species
Homo sapiens (Human)
Isotype
IgG
Purification Method
Antigen Affinity purified
Concentration
It differs from different batches. Please contact us to confirm it.
Buffer
PBS with 0.1% Sodium Azide, 50% Glycerol, pH 7.3. -20°C, Avoid freeze / thaw cycles.
Tested Applications
ELISA,WB,IHC
Troubleshooting and FAQs
Storage
Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
Lead Time
Basically, we can dispatch the products out in 1-3 working days after receiving your orders. Delivery time maybe differs from different purchasing way or location, please kindly consult your local distributors for specific delivery time.

Customer Reviews and Q&A

 Customer Reviews

There are currently no reviews for this product.

Submit a Review here

Target Background

Function
Acts as a transcriptional repressor. Increases DNMT3B-mediated repressive transcriptional activity when DNMT3B is tethered to DNA. May link molecule between DNMT3B and other co-repressor proteins.
Gene References into Functions
  1. ZHX1 expression is correlated with renal cell carcinoma progression and poor survival. PMID: 28152006
  2. ZHX1 was found to play essential roles in the proliferation, migration, and invasion of cholangiocarcinoma cells, and its effect on the proliferation was mediated partially through EGR1. PMID: 27835650
  3. together, this study demonstrates that ZHX1 plays crucial roles in the progression of glioblastoma, and its findings suggest that ZHX1 be viewed as a potential prognostic maker and therapeutic target of glioblastoma. PMID: 28351300
  4. miR-199a-3p may function as a novel tumor promoter in gastric cancer and its oncogenic activity may involve the direct targeting and inhibition of ZHX1 PMID: 25448600
  5. Low expression of ZHX1 may be responsible for hepatocarcinogenesis. PMID: 24064680
  6. Study showed that ZHX1 is SUMOylated by Ubc9 with SUMO1 at the sites K159, K454, and K626 and that the SUMOylation of ZHX1 regulated the stability, ubiquitination and transcriptional activity of ZHX1. PMID: 23686912
  7. This study characterized features of ZHX-1 involved in nuclear localization, dimerization, and transcriptional activity, and mapped these domains. PMID: 12237128
  8. a search of ZHX1-interacting proteins using a yeast two-hybrid system PMID: 12659632
  9. ZHX proteins 1, 2 and 3 are major transcriptional mediators of podocyte disease PMID: 17056598
  10. ZHX1 enhanced the transcriptional repression mediated by DNMT3B when DNMT3B is directly targeted to DNA. These results showed for the first the direct linkage between DNMT and zinc-fingers homeoboxes protein, leading to enhanced gene silencing by DNMT3B PMID: 17303076
  11. structure of the tandem zinc-finger region of human ZHX1 PMID: 19348505

Show More

Hide All

Subcellular Location
Nucleus. Note=Colocalized in the nucleus with DNMT3B.
Protein Families
ZHX family
Tissue Specificity
Ubiquitously expressed. Expressed in podocytes.
Database Links

HGNC: 12871

OMIM: 604764

KEGG: hsa:11244

STRING: 9606.ENSP00000297857

UniGene: Hs.521800

icon of phone
Call us
301-363-4651 (Available 9 a.m. to 5 p.m. CST from Monday to Friday)
icon of address
Address
7505 Fannin St., Ste 610, Room 7 (CUBIO Innovation Center), Houston, TX 77054, USA
icon of social media
Join us with

Subscribe newsletter

Leave a message

* To protect against spam, please pass the CAPTCHA test below.
CAPTCHA verification
© 2007-2024 CUSABIO TECHNOLOGY LLC All rights reserved. 鄂ICP备15011166号-1
Place an order now

I. Product details

*
*
*
*

II. Contact details

*
*

III. Ship To

*
*
*
*
*
*
*

IV. Bill To

*
*
*
*
*
*
*
*